ABSTRACT The human pathogen Staphylococcus aureus encodes a specialized type VII secretion system (T7SS), which plays an important role in bacterial virulence during infection. However, the functions of the T7SS during infection and in bacterial physiology remain unclear. Here, we demonstrate that S. aureus strains lacking a T7SS effector, EsxC (Δ esxC ), were highly sensitive to the important last resort drug, daptomycin, as well as other membrane-targeting antibiotics, including gramicidin and bithionol. To understand how EsxC mediates increased antibiotic sensitivity, we investigated the Δ esxC cell envelope. Scanning electron microscopy analysis of the esxC mutant revealed a distinct cell surface morphology. Δ esxC also displayed a decrease in membrane fluidity, altered membrane protein profiles, and altered cell wall synthesis. The esxC mutant membranes demonstrated an increased negative charge compared to the WT, which was associated with an enhanced daptomycin binding. We then showed that calcium ions, which are required for daptomycin activity, impacted growth of Δ esxC and sensitivity to daptomycin, suggesting that EsxC is involved in modulating calcium binding to the membrane. Furthermore, the esxC mutant displayed a heightened susceptibility to daptomycin during intracellular infection and in a murine skin infection model. Thus, our data show that the T7SS protein EsxC, in association with other T7SS proteins, contributes to the sensitivity of S. aureus to membrane-acting drugs, such as daptomycin, through modulation of cell membrane integrity. IMPORTANCE Type VII secretion system (T7SS) has a range of functions in bacteria, including specific roles in bacterial physiology, including DNA uptake, membrane integrity, and bacterial development. In S. aureus, T7SS has been shown to be critical for bacterial virulence, intra-species competition, and in host cell interactions, although their functions in bacterial physiology are not clear. Here, we report a role of the staphylococcal T7SS component EsxC in the modulation of the cell membrane and surface integrity, likely in association with co-dependent effectors, which impacts the activity of membrane targeting drugs like daptomycin. Our data indicate that targeting the T7SS could provide a new approach to enhancing activity of existing therapeutic agents.
Smith et al. (Mon,) studied this question.